Alpha2-adrenergic agonists for the reduction or discontinuation of opioids or opioid substitution therapy a review of clinical effectiveness and guidelines
Using alpha2-adrenergic agonists may be effective in opioid reduction or discontinuation relative to other supportive interventions or opioid substitution therapies. Further, there may be differences in effectiveness between alpha2-adrenergic agonists in themselves. This review considered the eviden...
| Main Authors: | , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
2018, February 23, 2018
|
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographic references